(Q34470018)

2 August 2017

1 reference

title

Rheumatic manifestations of parvovirus B19 infection (English)

1 reference

2 August 2017

Naides SJ

1

1 reference

2 August 2017

1 May 1998

1 reference

Rheumatic Diseases Clinics of North America

2 August 2017

1 reference

2 August 2017

24

1 reference

2 August 2017

375-401

1 reference

2 August 2017

2

1 reference

The structure of human parvovirus B19 at 8 A resolution

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Epidemic Erythema Infectiosum

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Experimental parvoviral infection in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Human parvovirus, the cause of erythema infectiosum (fifth disease)?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Diagnosis of human parvovirus infection by dot-blot hybridization using cloned viral DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

An outbreak of erythema infectiosum associated with human parvovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

The human parvovirus. Brief review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Prospective study of human parvovirus (B19) infection in pregnancy. Public Health Laboratory Service Working Party on Fifth Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Sequence of the right hand terminal palindrome of the human B19 parvovirus genome has the potential to form a 'stem plus arms' structure.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Transient expression of B19 parvovirus gene products in COS-7 cells transfected with B19-SV40 hybrid vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Human parvovirus B19 infection among hospital staff members after contact with infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Autoimmune haemolytic anaemia revealed by human parvovirus linked erythroblastopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

In vitro identification of a B19 parvovirus promoter.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Letter: Erythema infectiosum (fifth disease)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Erythrocyte P antigen: cellular receptor for B19 parvovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

An amplified ELISA for the detection of parvovirus B19 IgM using monoclonal antibody to FITC.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Haemagglutination by parvovirus B19

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Evaluation of five commercial tests for detection of immunoglobulin M antibodies to human parvovirus B19.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Intranuclear inclusions in marrow of hydropic fetus due to parvovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Papular-purpuric gloves-and-socks syndrome related to cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Persistent human parvovirus B19 infection following an acute infection with meningitis in an immunocompetent patient

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Intrauterine infection with human parvovirus B19: a light and electron microscopy study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Electron microscopic detection of human parvovirus (B19) in a patient with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Detection of human parvovirus using a molecularly cloned probe

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Polymerase chain reaction assay of parvovirus B19 DNA in clinical specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

The prevalence of antibody to human parvovirus B19 in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Human parvovirus infection in early rheumatoid and inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Dual infection with rubella and human parvovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

IgM serology for rubella and human parvovirus B19.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Multiple glycosphingolipids determine the tissue tropism of parvovirus B19.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Polyarteritis nodosa and parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Association of Wegener's granulomatosis with parvovirus B19 infection: comment on the concise communication by Nikkari et al

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Parvovirus-like particles in human sera

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Characterization and Molecular Cloning of a Human Parvovirus Genome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

A genome-linked copy of the NS-1 polypeptide is located on the outside of infectious parvovirus particles

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Erythema infectiosum: an outbreak of "slapped cheek" disease in north Devon

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Use of recombinant human parvovirus B19 antigens in serological assays

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Human parvovirus infection and aplastic crisis in hereditary spherocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Pure red cell aplasia due to parvovirus B19 infection in a man with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Cloning of the human parvovirus B19 genome and structural analysis of its palindromic termini

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Neuralgic amyotrophy due to parvovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Human herpesvirus 7 in patients with pityriasis rosea. Electron microscopy investigations and polymerase chain reaction in mononuclear cells, plasma and skin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Aplastic crisis due to parvovirus infection in pyruvate kinase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Human parvovirus aplasia: case due to cross infection in a ward

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Chronic parvovirus infection in a presumably immunologically healthy woman

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Numbness and tingling of fingers associated with parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Detection of B19 Parvovirus in Human Fetal Tissues by Electron Microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Persistent parvovirus B19 infections in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

A cyclized peptide for studies of human parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

A new peptide for human parvovirus B19 antibody detection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

A combined pseudoreplica-immunochemical technique for research and diagnostic virology

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Microplate capture hybridization of amplified parvovirus B19 DNA fragment labelled with digoxigenin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Human parvovirus and fetal anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Parvovirus infection in a family associated with aplastic crisis in an affected sibling pair with hereditary spherocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Papular-purpuric gloves and socks syndrome with hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Influence of previous exposure to human parvovirus B19 infection in explaining susceptibility to rheumatoid arthritis: an analysis of disease discordant twin pairs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Human parvovirus B19-induced transient pancytopenia in a child with hereditary spherocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

In situ hybridization for the detection of human parvovirus B19 nucleic acid sequences in paraffin-embedded specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Parvovirus B19 infection associated with encephalitis in a patient suffering from malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

The adeno-associated virus Rep78 gene inhibits cellular transformation induced by bovine papillomavirus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Absence of parvovirus B19 infection in chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Parvovirus B19 infection--persistence and genetic variation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

HLA and acute arthritis following human parvovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Electron microscopic identification of parvovirus virions in erythroid-line cells in fatal hydrops fetalis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

A synthetic parvovirus B19 capsid protein can replace viral antigen in antibody-capture enzyme immunoassays

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Detection of human parvovirus B19 DNA by using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Aseptic meningitis caused by parvovirus B19.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Cross-reactions in rubella and parvovirus specific IgM tests

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Immune response to B19 parvovirus and an antibody defect in persistent viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Chronic bone marrow failure due to persistent B19 parvovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Erythema infectiosum. An elementary school outbreak

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Human parvovirus associated with erythroblastopenia in iron deficiency anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Human parvovirus and aplastic crisis in chronic hemolytic anemias: a study of 24 observations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Six cases of hereditary spherocytosis revealed by human parvovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Human parvovirus and thalassaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Parvovirus and idiopathic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Familial human parvovirus infection associated with anemia in siblings with heterozygous beta-thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Polyarteritis nodosa and parvovirus B19

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Fibromyalgia and parvovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Human parvovirus arthropathy and rheumatoid factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Aplastic crisis caused by human parvovirus in two patients with hereditary stomatocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Non-permissiveness of synovial membrane cells to human parvovirus B19 in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Structure and mapping of the DNA of human parvovirus B19

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Dot blot hybridization assay of B19 virus DNA in clinical specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Expression of the human parvovirus B19 protein fused to protein A in Escherichia coli: recognition by IgM and IgG antibodies in human sera.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Should measures be taken to reduce the risk of human parvovirus (B19) infection by transfusion of blood components and clotting factor concentrates?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Viral-associated haemophagocytosis with parvovirus-B19-related pancytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

1 reference

7 January 2021

Human parvovirus B19-induced vesiculopustular skin eruption

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Rheumatologic manifestations of human parvovirus B19 infection in adults. Initial two-year clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Antenatal diagnosis and palliative treatment of non-immune hydrops fetalis secondary to fetal parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Does parvovirus B19 have a role in rheumatoid arthritis?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Wegener's granulomatosis and parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Persistence of parvovirus B19 in synovial fluid and bone marrow.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Parvovirus B19 in rheumatoid arthritis: comment on the article by Kerr et al

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Human parvovirus B19-associatedarthritis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Human parvovirus (B19) and erythema infectiosum

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Detection of antibodies to human parvovirus in erythema infectiosum (fifth disease)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Novel transcription map for the B19 (human) pathogenic parvovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Evaluation of commercial enzyme linked immunosorbent assay for detection of B19 parvovirus IgM and IgG

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Parvovirus infections and hypoplastic crisis in sickle-cell anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Human parvovirus B19 and blood products

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Infection with parvovirus-like virus and aplastic crisis in chronic hemolytic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Aplastic crisis in occult hereditary spherocytosis caused by human parvovirus (HPV B19)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Aplastic crisis due to human B19 parvovirus infection in red cell pyrimidine-5'-nucleotidase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Intrauterine transfusion treatment of nonimmune hydrops fetalis secondary to human parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Detection of parvovirus B19 DNA in fetal tissues by in situ hybridisation and polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Recombinant parvovirus B19 capsids as a new substrate for detection of B19-specific IgG and IgM antibodies by an enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Acute bilateral carpal tunnel syndrome associated with human parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Identification of the region including the epitope for a monoclonal antibody which can neutralize human parvovirus B19.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Parvovirus B19 infection of the fetus. Histology and in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Human parvovirus B19 arthropathy in two adults after contact with childhood erythema infectiosum

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Human parvovirus (HPV/B19) infection with purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Parvovirus B19-associated haemophagocytic syndrome in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Febrile illness due to a parvovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

The 1987 revised American Rheumatism Association criteria for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Intrauterine blood transfusion for non-immune hydrops fetalis due to parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Glycosphingolipids: structure, biological source, and properties

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Human parvovirus infection revealing hereditary spherocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Characterization of the Genome of the Agent of Erythrocyte Aplasia Permits its Classification as a Human Parvovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Neonatal meningitis with human parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Inhibition of erythropoiesis by human parvovirus-containing serum from a patient with hereditary spherocytosis in aplastic crisis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Rolling hairpin model for replication of parvovirus and linear chromosomal DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Production of parvovirus B19 vaccine in insect cells co-infected with double baculoviruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

The three-dimensional structure of canine parvovirus and its functional implications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Epidemic of aplastic crisis in patients with hereditary spherocytosis in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

A new genome type of human parvovirus B19 present in sera of patients with encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

First picture of erythema infectiosum?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Parvovirus B19 infection and idiopathic thrombocytopenic purpura.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

User's guide to some new tests for hepatitis-B antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Antibodies to parvovirus B19 NS-1 protein in infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: implications for pathogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Viral-associated haemophagocytosis and elevated serum TNF-alpha with parvovirus-B19-related pancytopenia in patients with hereditary spherocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Parvovirus infection associated with aplastic crisis in a patient with HEMPAS

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

HUMAN PARVOVIRUS ARTHROPATHY

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Clinical manifestations of human parvovirus B19 in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

The canine parvovirus empty capsid structure

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Transmission of symptomatic parvovirus B19 infection by clotting factor concentrate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Human parvovirus B19 infection associated with acute hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

The immune system as mediator of virus-associated bone marrow failure: B19 parvovirus and Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Parvovirus B19-associated haemophagocytic syndrome with lymphadenopathy resembling histiocytic necrotizing lymphadenitis (Kikuchi's disease).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Automated detection of digoxigenin-labelled B19 parvovirus amplicons by a capture hybridization assay

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

Evaluation of strand-specific RNA probes visualized by colorimetric and chemiluminescent reactions for the detection of B19 parvovirus DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970014-4

7 January 2021

10.1016/S0889-857X(05)70014-4

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

9606764